Study of Oral Weekly GS-1720 and GS-4182 Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed

NYU Langone Health Vaccine Center, New York

NewYork-Presbyterian Queens, Flushing

Georgetown University Medical Center, Washington D.C.

Rosedale Health and Wellness, Huntersville

Metro Infectious Disease Consultants, P.L.L.C., Decatur

Mercer University, Department of Internal Medicine, Macon

Chatham County Health Department, Savannah

Midland Florida Clinical Research Center, LLC, DeLand

Orlando Immunology Center, Orlando

Floridian Clinical Research, Miami Lakes

AIDS Healthcare Foundation - The Kinder Medical Group, Miami

CAN Community Health, Fort Lauderdale

Triple O Research Institute, P.A., West Palm Beach

CAN Community Health, Sarasota

Midway and Immunology Research Center, Ft. Pierce

UAB 1917 Research Clinic, Birmingham

Be Well Medical Center, Berkley

KC CARE Health Center, Kansas City

Prism Health North Texas, Oak Cliff Health Center, Dallas

North Texas Infectious Diseases Consultants, PA, Dallas

DCOL Center for Clinical Research, Longview

Texas Centers for Infectious Disease Associates, Fort Worth

The Crofoot Research Center, INC., Houston

St Hope Foundation, Inc., Bellaire

Central Texas Clinical Research, Austin

AXCES Research Group, LLC, El Paso

AXCES Research Group, LLC, Santa Fe

Ruane Clinical Research Group, Los Angeles

Mills Clinical Research, Los Angeles

Pacific Oaks Medical Group, Beverly Hills

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance

BIOS Clinical Research, Palm Springs

UCSF Division of HIV, Infectious Diseases & Global Medicine, San Francisco

Peter Shalit, MD, Seattle

Saint Michael's Medical Center, Newark

Centro Ararat, Inc., San Juan

Clinical Research Puerto Rico, San Juan

HOPE Clinical Research, San Juan

Proyecto ACTC, San Juan